TNDM - Tandem Diabetes Care Inc
IEX Last Trade
43.45
-0.750 -1.726%
Share volume: 1,006,826
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$44.20
-0.75
-1.70%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-02 | 2023-02-22 | 2023-05-03 | 2023-08-03 | 2023-11-01 | 2024-02-21 | 2024-05-02 | 2024-08-01 | |
| Assets | |||||||||
| Total Assets | 1.048 B | 1.053 B | 954.145 M | 946.676 M | 939.909 M | 952.658 M | 941.045 M | 937.503 M | |
| Current Assets | 834.303 M | 849.976 M | 757.919 M | 764.304 M | 758.144 M | 747.989 M | 735.193 M | 733.388 M | |
| Inventories | 104.774 M | 111.117 M | 131.557 M | 147.599 M | 143.492 M | 157.937 M | 153.893 M | 161.661 M | |
| Other Current Assets | 7.997 M | 7.241 M | 15.381 M | 10.745 M | 16.176 M | 16.585 M | 20.525 M | 21.195 M | |
| Short Term Investments | 7.997 M | 7.241 M | 15.381 M | 10.745 M | 16.176 M | 16.585 M | 20.525 M | 21.195 M | |
| Total Receivables | 112.805 M | 114.717 M | 91.393 M | 98.714 M | 100.318 M | 105.555 M | 92.965 M | 98.117 M | |
| Current Cash | 608.727 M | 616.901 M | 519.588 M | 507.246 M | 498.158 M | 467.912 M | 467.810 M | 452.415 M | |
| Total Non-current Assets | 213.217 M | 202.809 M | 196.226 M | 182.372 M | 181.765 M | 204.669 M | 205.852 M | 204.115 M | |
| Property Plant Equipment | 72.905 M | 68.552 M | 74.578 M | 73.752 M | 75.760 M | 76.542 M | 77.530 M | 78.626 M | |
| Other Assets | 23.838 M | 15.331 M | 16.905 M | 17.566 M | 16.571 M | 40.336 M | 40.036 M | 37.246 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.048 B | 1.053 B | 954.145 M | 946.676 M | 939.909 M | 952.658 M | 941.045 M | 937.503 M | |
| Total liabilities | 625.698 M | 612.838 M | 615.392 M | 617.442 M | 625.909 M | 639.026 M | 697.981 M | 703.628 M | |
| Total current liabilities | 173.630 M | 165.290 M | 171.157 M | 174.655 M | 187.110 M | 195.258 M | 192.971 M | 240.610 M | |
| Accounts Payable | 61.531 M | 55.730 M | 55.231 M | 57.080 M | 46.142 M | 49.586 M | 48.143 M | 47.776 M | |
| Other liabilities | 42.172 M | 40.792 M | 39.689 M | 40.259 M | 38.207 M | 45.161 M | 44.781 M | 44.234 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 40.540 M | |
| Long term debt | 282.787 M | 283.232 M | 283.679 M | 284.128 M | 284.580 M | 285.035 M | 347.497 M | 307.392 M | |
| Other liabilities | 42.172 M | 40.792 M | 39.689 M | 40.259 M | 38.207 M | 45.161 M | 44.781 M | 44.234 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 421.822 M | 439.947 M | 338.753 M | 329.234 M | 314.000 M | 313.632 M | 243.064 M | 233.875 M | |
| Common stock | 64.236 M | 64.391 M | 64.549 M | 64.830 M | 65.117 M | 65.380 M | 65.326 M | 64.994 M | |
| Retained earnings | -713.336 M | -729.189 M | -853.062 M | -888.837 M | -921.798 M | -951.800 M | -994.515 M | -1.025 B |